Type 2 diabetes trials recruiting in California

All Type 2 diabetes trials nationally

Cities in California

Recruiting trials in California

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
  NCT07351045 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, San Diego, Walnut Creek
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Lake Forest, Long Beach, Montclair, Norco
• A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
  NCT07260110 · Phase: Not specified · Ages: 8 Years and older · Sex: All (male and female) · California: San Francisco
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Lynwood, Rolling Hills Estates, Sacramento
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
  NCT07662044 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Lomita, Los Alamitos, San Diego, Walnut Creek
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Concord, Sacramento, Victorville
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
  NCT07664553 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Bakersfield, Los Angeles, Ontario
• A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy
  NCT05577390 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 85 Years · Sex: All (male and female) · California: Loma Linda
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
  NCT06112418 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · California: Beverly Hills, Canoga Park, Chula Vista, Granada Hills
• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
  NCT07061574 · Phase: Phase 1, Phase 2 · Ages: 9 Years to 20 Years · Sex: All (male and female) · California: San Francisco
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Dimas, San Ramon
• A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07415954 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Lancaster, Lomita, Long Beach, Los Alamitos
• A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
  NCT07668388 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Fountain Valley, Long Beach, Los Angeles, Montclair
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido, La Mesa, Lincoln, Loma Linda
• A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
  NCT04786262 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Duarte, San Francisco
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · California: Escondido, Fountain Valley, La Jolla, Lake Forest
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
  NCT07340320 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Cerritos, Long Beach, Walnut Creek
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
  NCT06739122 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · California: Los Angeles, San Francisco
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Canoga Park, Escondido, Greenbrae, Long Beach
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido, Fountain Valley, Palm Springs, Rolling Hills Estates
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine, La Jolla, La Mesa, Rolling Hills Estates
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
  NCT06897475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Santa Ana
• A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
  NCT06924320 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Cypress
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Banning, Chula Vista, Covina, Gardena
• A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
  NCT07724340 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Anaheim
• A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
  NCT07465224 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Chula Vista
• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
  NCT07776509 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido, Lincoln, Walnut Creek
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido
• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla
• A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
  NCT07662213 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Covina, Encinitas, Garden Grove, Loma Linda
• A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
  NCT07606066 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Lincoln
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Glendale
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Greenbrae, Huntington Park, Rolling Hills Estates, Walnut Creek
• A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
  NCT07723833 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · California: Glendale
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Canoga Park, Escondido, Modesto, Sacramento
• A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
  NCT07754461 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Canoga Park, Concord, Escondido, Lincoln
• A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
  NCT07590193 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Lake Forest
• A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)
  NCT07355270 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · California: Newport Beach
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido, Lomita, Walnut Creek
• AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
  NCT07797335 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · California: Lancaster, Lincoln, Lomita, Los Alamitos
• Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
  NCT07478263 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: Female · California: La Jolla
• CGM for Management of Type 2 Diabetes in Pregnancy
  NCT06628453 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female · California: San Diego
• Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
  NCT07065721 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · California: San Diego
• DETERMINE: Detemir vs NPH
  NCT05124457 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
  NCT06525259 · Phase: Not specified · Ages: 8 Years to 15 Years · Sex: All (male and female) · California: Los Angeles
• Denosumab for Type 1 Diabetes
  NCT06524960 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · California: Duarte
• Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
  NCT05416060 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Chula Vista, San Diego
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Beverly Hills, Canoga Park, Concord, Huntington Park
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
  NCT05708859 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · California: Torrance
• Efficacy of Using Mobile Health Applications for Health
  NCT05589155 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · California: San Diego
• Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
  NCT05279729 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · California: San Diego
• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
  NCT07579702 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 75 Years · Sex: All (male and female) · California: Los Angeles, Santa Barbara
• Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
  NCT06296550 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
  NCT07521475 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Los Angeles, Newport Beach, Santa Barbara, Vallejo
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · California: Canoga Park, Cerritos, Chula Vista, Pomona
• Food Insecurity Reduction & Strategy Team
  NCT06329375 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto
• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
  NCT07228117 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 85 Years · Sex: All (male and female) · California: Escondido, Goleta, Loma Linda, Sacramento
• Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
  NCT07386340 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido
• HOPE Intervention for Fitness
  NCT07114822 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Irvine
• HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
  NCT07546929 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Canoga Park
• High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
  NCT06662994 · Phase: Phase 4 · Ages: 21 Years and older · Sex: All (male and female) · California: Fullerton
• Implementation of Team Clinic for Type 2 Diabetes (TCT2)
  NCT06923046 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · California: Los Angeles, San Francisco
• Implementing Food Referrals for Equity and Sustained Health
  NCT06661538 · Phase: Phase 2 · Ages: 5 Years and older · Sex: All (male and female) · California: La Jolla, San Diego
• Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
  NCT06251323 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Stanford
• Latinos Understanding the Need for Adherence in Diabetes Using E-Health
  NCT05570734 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Chula Vista
• Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
  NCT05165706 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 65 Years · Sex: All (male and female) · California: Stanford
• More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus
  NCT05138432 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 18 Years · Sex: All (male and female) · California: San Diego
• New T-UP: Engaging Vulnerable Students in Diabetes Prevention
  NCT07225218 · Phase: Not applicable (e.g. observational or device study) · Ages: 17 Years to 25 Years · Sex: All (male and female) · California: Los Angeles
• Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
  NCT06657209 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · California: Palo Alto, Stanford
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · California: Los Angeles
• Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
  NCT06964087 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · California: Walnut Creek
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
  NCT07502508 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Canoga Park, Long Beach, Montclair, San Diego
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
  NCT07502495 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Canoga Park, Fountain Valley, Long Beach, Montclair
• Post Prandial Individual Responses to Different Foods
  NCT06989164 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Stanford
• Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
  NCT07449039 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: Los Angeles
• Precision Dosing of Metformin in Youth With T2D
  NCT06120881 · Phase: Early Phase 1 · Ages: 10 Years to 21 Years · Sex: All (male and female) · California: Oakland, San Francisco
• Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
  NCT07176793 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• Project Dulce for Arab Americans With Type 2 Diabetes
  NCT05580536 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: El Cajon
• ROME GS System Study
  NCT07518004 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Escondido, Walnut Creek
• Registry for Stage 2 Type 1 Diabetes
  NCT06481904 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · California: Los Angeles, San Francisco
• Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
  NCT06681428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Fresno, Los Angeles, Vista
• Safer Aging With Diabetes Monitoring
  NCT06296485 · Phase: Not applicable (e.g. observational or device study) · Ages: 75 Years and older · Sex: All (male and female) · California: Fremont, Sacramento, San Jose, San Leandro
• Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
  NCT06999356 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · California: Santa Barbara
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Huntington Beach, Northridge, Oxnard, Salinas
• THC Effects on Glucose in Type 2 Diabetes
  NCT05322213 · Phase: Phase 1 · Ages: 21 Years to 70 Years · Sex: All (male and female) · California: La Jolla
• Time Restricted Eating in Patients With Microalbuminuria
  NCT06884059 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: La Jolla
• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
  NCT07296484 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Fountain Valley, Huntington Park, La Mesa, Long Beach
• Type 2 Continuous Glucose Monitoring Academy
  NCT06516640 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 21 Years · Sex: All (male and female) · California: Los Angeles
• Type 2 Diabetes and Blood Brain Barrier Improvement
  NCT06322212 · Phase: Early Phase 1 · Ages: 40 Years to 65 Years · Sex: All (male and female) · California: Los Angeles
• Use of CGM in Kidney Transplant Recipients
  NCT04783441 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
  NCT06836479 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Stanford